SOPH 財務： SOPHiA GENETICS SA AI 分析

首頁

股票

SOPH

SOPH 財務

SOPHiA GENETICS SA

0%

$0

收盤價：Feb 17, 16:00:00 GMT-5

0%

$0

盤後：Feb 17, 17:10:57 GMT-5

概觀預測收益股利財務狀況

關鍵數據

前收市價

開盤價

當日範圍

52週區間

交易量

平均成交量

172.4K

每股盈餘 (TTM)

-1.12

股息收益率

市值

什麼是 SOPH？

SOPHiA GENETICS SA is a healthcare technology company, which engages in the practice of data driven medicine as the standard of care and for life sciences research. The company is headquartered in Rolle, Vaud and currently employs 423 full-time employees. The company went IPO on 2021-07-23. The Company’s key product is SOPHiA DDM, which is a cloud-native software-as-a-service (SaaS) platform. The platform analyses multimodal data, including genomics, radiomics, clinical, biological, and digital pathology data, to generate actionable insights for patients with cancer or rare diseases, bringing the power of data-driven medicine to patients across the globe. Additionally, the Company aids BioPharma partners with artificial-intelligence-powered drug discovery, development, and deployment. The firm has offices in Switzerland, France, and the United States and operates worldwide.

功能特性

資源

市場

收入

資產負債表

現金流量

年度

每季

SOPH 收入

財務數據以百萬美元計。會計年度為二月至一月。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
營收	73	65	62	47	40	28
營收年增率 (YoY)	14%	5%	32%	18%	43%	12%
營收成本	23	21	19	16	15	10
毛利	49	43	42	31	25	17
銷售、一般及管理費用	83	76	77	81	68	34
研發	34	34	34	33	25	17
營業費用	118	110	117	119	96	55
其他非營業收入 (費用)	0	0	0	0	0	0
稅前淨利	-72	-61	-78	-87	-73	-41
所得稅費用	2	1	0	0	0	-1
淨利	-74	-62	-78	-87	-73	-39
淨利成長	4%	-21%	-10%	19%	87%	18%
稀釋後流通股數	67.78	66.06	64.75	64.1	55.3	63.34
股數年變動 (YoY)	2%	2%	1%	16%	-13%	0%
每股盈餘 (稀釋)	-1.11	-0.94	-1.21	-1.36	-1.33	-0.62
每股盈餘成長率	3%	-22%	-10%	2%	114.99%	17%
自由現金流	-46	-50	-57	-80	-64	-34
每股自由現金流	--	--	--	--	--	--
毛利率	67.12%	66.15%	67.74%	65.95%	62.5%	60.71%
營業利益率	-93.15%	-101.53%	-119.35%	-185.1%	-177.5%	-132.14%
淨利率	-101.36%	-95.38%	-125.8%	-185.1%	-182.5%	-139.28%
自由現金流利潤率	-63.01%	-76.92%	-91.93%	-170.21%	-160%	-121.42%
EBITDA	-59	-58	-66	-82	-68	-35
EBITDA 利潤率	-80.82%	-89.23%	-106.45%	-174.46%	-170%	-125%
EBITDA 中的折舊與攤銷	9	8	8	5	3	2
EBIT	-68	-66	-74	-87	-71	-37
EBIT 利潤率	-93.15%	-101.53%	-119.35%	-185.1%	-177.5%	-132.14%
有效稅率	-2.77%	-1.63%	0%	0%	0%	2.43%

SOPHiA GENETICS SA（SOPH）價格

SOPH 股價走勢圖